FNDX | IVE | FNDX / IVE | |
Gain YTD | 3.590 | 2.373 | 151% |
Net Assets | 17.9B | 35.6B | 50% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 12.00 | 29.00 | 41% |
Yield | 1.71 | 1.62 | 106% |
Fund Existence | 11 years | 25 years | - |
FNDX | IVE | |
---|---|---|
RSI ODDS (%) | N/A | 16 days ago86% |
Stochastic ODDS (%) | 16 days ago90% | 16 days ago88% |
Momentum ODDS (%) | 16 days ago79% | 16 days ago76% |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 16 days ago84% | 16 days ago84% |
TrendMonth ODDS (%) | 16 days ago77% | 16 days ago77% |
Advances ODDS (%) | 18 days ago84% | 18 days ago82% |
Declines ODDS (%) | 25 days ago74% | 25 days ago74% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 16 days ago75% | 16 days ago83% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JHID | 28.64 | 0.81 | +2.91% |
JHancock International High Dividend ETF | |||
UMAY | 34.09 | 0.05 | +0.16% |
Innovator U.S. Equity Ultra BffrETF™-May | |||
PFEB | 37.07 | 0.05 | +0.14% |
Innovator US Equity Power Bffr ETF™ Feb | |||
TOTL | 39.41 | -0.04 | -0.10% |
SPDR® DoubleLine® Total Return Tact ETF | |||
XPH | 44.50 | -0.20 | -0.45% |
SPDR® S&P Pharmaceuticals ETF |
A.I.dvisor indicates that over the last year, IVE has been closely correlated with BLK. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVE jumps, then BLK could also see price increases.